Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Plos One
|
December 22, 2018
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment
Fredrika Koskimäki, Jacqueline Bernard, Jeong Yong, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 19, 2022
Increased Percentage of CD8<sup>+</sup>CD28<sup>-</sup> Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
Timothy W Houston, Quentin Howlett-Prieto, Colin Regenauer, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
May 15, 2012
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica
Rebecca S Romero, Ismael Gutierrez, Eugene Wang, et al.
Plos One
|
December 6, 2011
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS
Douglas S Goodin, Jason Jones, David Li, et al.
Current Medical Research and Opinion
|
August 15, 2009
Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command
Mark S Freedman, Bruce Cohen, Suhayl Dhib-Jalbut, et al.
CNS Drugs
|
July 6, 2021
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
Stanley L Cohan, Barry A Hendin, Anthony T Reder, et al.
Physiological Reports
|
December 8, 2025
Impaired inactive limb blood flow regulation in adults with multiple sclerosis during sympathoexcitatory stimuli
Sara R Sherman, Natalia S Lima, Robert W Motl, et al.
Ophthalmology
|
March 28, 2013
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
Marco A Zarbin, Lee M Jampol, Rama D Jager, et al.
Journal of the Neurological Sciences
|
November 1, 2011
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
Xuan Feng, Nicholas P Reder, Mounica Yanamandala, et al.
Frontiers in Immunology
|
May 22, 2023
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients
Kiel M Telesford, Lilyana Amezcua, Lauren Tardo, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Plos One
|
December 22, 2018
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment
Fredrika Koskimäki, Jacqueline Bernard, Jeong Yong, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 19, 2022
Increased Percentage of CD8<sup>+</sup>CD28<sup>-</sup> Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
Timothy W Houston, Quentin Howlett-Prieto, Colin Regenauer, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
May 15, 2012
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica
Rebecca S Romero, Ismael Gutierrez, Eugene Wang, et al.
Plos One
|
December 6, 2011
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS
Douglas S Goodin, Jason Jones, David Li, et al.
Current Medical Research and Opinion
|
August 15, 2009
Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command
Mark S Freedman, Bruce Cohen, Suhayl Dhib-Jalbut, et al.
CNS Drugs
|
July 6, 2021
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
Stanley L Cohan, Barry A Hendin, Anthony T Reder, et al.
Physiological Reports
|
December 8, 2025
Impaired inactive limb blood flow regulation in adults with multiple sclerosis during sympathoexcitatory stimuli
Sara R Sherman, Natalia S Lima, Robert W Motl, et al.
Ophthalmology
|
March 28, 2013
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
Marco A Zarbin, Lee M Jampol, Rama D Jager, et al.
Journal of the Neurological Sciences
|
November 1, 2011
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
Xuan Feng, Nicholas P Reder, Mounica Yanamandala, et al.
Frontiers in Immunology
|
May 22, 2023
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients
Kiel M Telesford, Lilyana Amezcua, Lauren Tardo, et al.
Page
of 9